Baxevanis, Constantin N <br/><br/>
In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Sep 2003 
 - 2953-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.171.6.2953  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adoptive Transfer<br/>Animals<br/>Antigens--biosynthesis<br/>Antigens, Surface<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>CD3 Complex--biosynthesis<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Cytotoxicity, Immunologic<br/>Fibrosarcoma--pathology<br/>Growth Inhibitors--administration & dosage<br/>Interferon-gamma--biosynthesis<br/>Interleukin-12--administration & dosage<br/>Interleukin-18--administration & dosage<br/>Interleukin-2--biosynthesis<br/>Killer Cells, Natural--immunology<br/>Lectins, C-Type<br/>Lymphocyte Activation--immunology<br/>Lymphoma, T-Cell--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, SCID<br/>NK Cell Lectin-Like Receptor Subfamily B<br/>Neoplasm Transplantation<br/>Protein Biosynthesis<br/>Proteins<br/>T-Lymphocyte Subsets--immunology